Research Articles | Page 13 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies Oct 2023 Blood Advances Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN)
Outpatient subcutaneous alemtuzumab is feasible and safe for aplastic anemia and is associated with high response rates Feb 2025 Blood Advances Aplastic Anemia
Consensus recommendations for severe aplastic anemia Nov 2024 Blood Advances Aplastic Anemia
Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia Oct 2019 Blood Advances Aplastic Anemia
Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study Jun 2023 Blood Advances Myelodysplastic Syndromes (MDS)
Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years Oct 2019 Blood Advances Aplastic Anemia
Pegcetacoplan controls hemolysis in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria Jun 2023 Blood Advances Paroxysmal Nocturnal Hemoglobinuria (PNH)
Consensus Recommendations for Severe Aplastic Anemia Aug 2024 Blood Advances Aplastic Anemia
Hemolysis events in the Phase 3 PEGASUS study of pegcetacoplan in patients with paroxysmal nocturnal hemoglobinuria Apr 2024 Blood Advances Paroxysmal Nocturnal Hemoglobinuria (PNH)
Modified Delphi panel consensus recommendations for management of severe aplastic anemia Aug 2024 Blood Advances Aplastic Anemia